journal article·2026-01Open access

Precise modulation of dissolution, therapeutic ion release, and biocompatibility in bioactive glasses

Brenna Kettlewell, Daniel Boyd

Abstract

Abstract This study investigates the controlled dissolution and ion release kinetics of multicomponent borate glasses within the borate anomaly, focusing on therapeutic ions such as calcium, zinc, and fluorine, which are critical in applications ranging from cancer therapy to bone regeneration and oral health. A Design of Mixtures (DoM) statistical modeling approach was employed to systematically evaluate the effects of glass composition on dissolution, ion release, and cytotoxicity. By synthesizing 23 glass formulations, the study demonstrates how statistical modeling enables precise prediction and control of material properties, revealing key interactions between components that are difficult to identify using traditional methods. Notably, higher ZnO content stabilized the glass network, reducing dissolution and ion release rates. The approach also uncovered complex synergies between zinc, titanium, and calcium, emphasizing the value of a multifactorial approach in optimizing glass performance. While higher ZnO concentrations (i.e., 16–20 mol%) correlated with increased cytotoxicity in human umbilical vein endothelial cells (HUVECs), several formulations exhibited no cytotoxic effects at a concentration of 0.2 g/mL, highlighting the need for careful compositional tuning. This research demonstrates how integrating experimental and computational methods can permit the design of glasses with tailored dissolution and ion release kinetics, enabling more effective, customizable, and personalized medical treatments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Laser-Ablation Synthesis of Nanoparticles · Facial Trauma and Fracture Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedical Engineering Dalhousie University Halifax Nova Scotia Canada

Department of Applied Oral Sciences, Faculty of Dentistry Dalhousie University Halifax Nova Scotia Canada

Funding

Natural Sciences and Engineering Research Council of Canada

References (100+)

Show source-provided references
1. 10.3390/molecules2619590510.3390/molecules26195905 ↗
2. 10.1016/j.heliyon.2023.e1748810.1016/j.heliyon.2023.e17488 ↗
3. 10.3390/nano1316228710.3390/nano13162287 ↗
4. 10.1159/00038169010.1159/000381690 ↗
5. 10.1098/rsif.2011.061110.1098/rsif.2011.0611 ↗
6. 10.1039/c2bm00116k10.1039/c2bm00116k ↗
7. MacDonaldK. “Strontium releasing composite resin cements [PhD thesis].” Halifax NS Canada: Dalhousie University;2019.
8. 10.1016/j.jconrel.2021.05.04310.1016/j.jconrel.2021.05.043 ↗
9. 10.1021/acsami.1c0751910.1021/acsami.1c07519 ↗
10. 10.2119/2008‐00033.Prasad10.2119/2008‐00033.Prasad ↗
11. 10.1016/j.ccr.2023.21553510.1016/j.ccr.2023.215535 ↗
12. 10.1002/advs.20210353410.1002/advs.202103534 ↗
13. 10.1016/j.bioactmat.2022.06.00510.1016/j.bioactmat.2022.06.005 ↗
14. 10.1038/srep2666110.1038/srep26661 ↗
15. 10.1021/acsbiomaterials.5b0031910.1021/acsbiomaterials.5b00319 ↗
16. 10.1152/ajpcell.00279.201710.1152/ajpcell.00279.2017 ↗
17. 10.1002/adma.20130022610.1002/adma.201300226 ↗
18. 10.1016/j.msec.2015.07.02210.1016/j.msec.2015.07.022 ↗
19. 10.1016/j.biomaterials.2017.08.02210.1016/j.biomaterials.2017.08.022 ↗
20. 10.1016/j.pmatsci.2020.10073210.1016/j.pmatsci.2020.100732 ↗
21. 10.1359/JBMR.05091710.1359/JBMR.050917 ↗
22. 10.1002/jor.2417010.1002/jor.24170 ↗
23. 10.1016/j.bioactmat.2017.05.00710.1016/j.bioactmat.2017.05.007 ↗
24. 10.1016/j.addr.2012.05.01510.1016/j.addr.2012.05.015 ↗
25. 10.1007/s00223990059710.1007/s002239900597 ↗
26. 10.4162/nrp.2010.4.5.35610.4162/nrp.2010.4.5.356 ↗
27. 10.1016/j.tibtech.2013.06.005.Trace10.1016/j.tibtech.2013.06.005.Trace ↗
28. 10.1016/j.actbio.2019.07.03410.1016/j.actbio.2019.07.034 ↗
29. 10.1016/j.jmst.2018.01.00610.1016/j.jmst.2018.01.006 ↗
30. 10.3389/fbioe.2022.84876910.3389/fbioe.2022.848769 ↗
31. 10.1038/srep1071910.1038/srep10719 ↗
32. 10.1016/j.biomaterials.2011.01.00410.1016/j.biomaterials.2011.01.004 ↗
33. 10.1039/c9bm01691k10.1039/c9bm01691k ↗
34. 10.1152/physrev.2000.80.3.121510.1152/physrev.2000.80.3.1215 ↗
35. 10.1016/S0006-3495(75)85849-810.1016/S0006-3495(75)85849-8 ↗
36. 10.1079/bjn/200253410.1079/bjn/2002534 ↗
37. 10.1101/cshperspect.a01135310.1101/cshperspect.a011353 ↗
38. 10.1016/j.neuron.2008.08.01910.1016/j.neuron.2008.08.019 ↗
39. Mikaelsson ME · 1991 · 2910.1007/978-1-4615-3900-1_3 ↗
40. 10.1038/s41598‐019‐47815‐z10.1038/s41598‐019‐47815‐z ↗
41. 10.1186/s40824‐018‐0149‐310.1186/s40824‐018‐0149‐3 ↗
42. 10.1016/j.actbio.2013.06.01410.1016/j.actbio.2013.06.014 ↗
43. 10.1016/j.dental.2008.10.00910.1016/j.dental.2008.10.009 ↗
44. 10.1038/nrm115010.1038/nrm1150 ↗
45. 10.1016/j.apsb.2016.11.00110.1016/j.apsb.2016.11.001 ↗
46. 10.1038/nrc217110.1038/nrc2171 ↗
47. 10.1016/j.bbamcr.2012.11.01610.1016/j.bbamcr.2012.11.016 ↗
48. 10.1146/annurev.immunol.021908.13255010.1146/annurev.immunol.021908.132550 ↗
49. 10.1038/ni129510.1038/ni1295 ↗
50. 10.1038/ni.f.22010.1038/ni.f.220 ↗
51. 10.1177/1045441191002003010110.1177/10454411910020030101 ↗
52. 10.1016/j.ceramint.2018.07.17510.1016/j.ceramint.2018.07.175 ↗
53. 10.1159/00038088610.1159/000380886 ↗
54. 10.14219/jada.archive.2000.030710.14219/jada.archive.2000.0307 ↗
55. 10.1038/sj.bdj.2013.16210.1038/sj.bdj.2013.162 ↗
56. 10.1159/00032515110.1159/000325151 ↗
57. 10.1139/m95-13310.1139/m95-133 ↗
58. 10.1177/002203451038462610.1177/0022034510384626 ↗
59. 10.1016/j.actbio.2005.09.00310.1016/j.actbio.2005.09.003 ↗
60. 10.1007/s00204‐020‐02725‐210.1007/s00204‐020‐02725‐2 ↗
61. 10.1111/ijag.1211310.1111/ijag.12113 ↗
62. 10.1111/j.1151‐2916.1938.tb15777.x10.1111/j.1151‐2916.1938.tb15777.x ↗
63. 10.3390/ma1709207310.3390/ma17092073 ↗
64. 10.1201/978131538232610.1201/9781315382326 ↗
65. 10.1055/s‐0040‐170129210.1055/s‐0040‐1701292 ↗
66. “ISO 10993‐12: Biological evaluation of medical devices—Part 12: sample preparation and reference materials.”
67. “ISO 10993–5: Biological evaluation of medical devices—Part 5: tests for in vitro cytotoxicity.”2009.
68. 10.1016/j.jnoncrysol.2011.05.03110.1016/j.jnoncrysol.2011.05.031 ↗
69. 10.1111/ijag.1586710.1111/ijag.15867 ↗
70. 10.1016/j.jnoncrysol.2015.07.00310.1016/j.jnoncrysol.2015.07.003 ↗
71. Brow RK · 2022 · 282
72. 10.1016/B978-0-08-057150-8.50025-210.1016/B978-0-08-057150-8.50025-2 ↗
73. 10.1111/ijag.1205210.1111/ijag.12052 ↗
74. 10.1016/j.jnoncrysol.2018.02.01110.1016/j.jnoncrysol.2018.02.011 ↗
75. The effect of molecular structure on borosilicate glass leaching
76. 10.1016/0022-3093(91)90443-A10.1016/0022-3093(91)90443-A ↗
77. 10.1016/j.jnoncrysol.2023.12240610.1016/j.jnoncrysol.2023.122406 ↗
78. 10.1016/j.actbio.2008.10.02010.1016/j.actbio.2008.10.020 ↗
79. 10.1088/1748‐6041/6/3/03500610.1088/1748‐6041/6/3/035006 ↗
80. 10.1021/jp020321s10.1021/jp020321s ↗
81. 10.1016/j.msec.2019.10991010.1016/j.msec.2019.109910 ↗
82. 10.1016/j.ceramint.2011.07.06910.1016/j.ceramint.2011.07.069 ↗
83. 10.1039/d2cp05517a10.1039/d2cp05517a ↗
84. 10.1039/d2tb02505a10.1039/d2tb02505a ↗
85. 10.1111/jcpe.1305810.1111/jcpe.13058 ↗
86. 10.1002/jbm.a.3145410.1002/jbm.a.31454 ↗
87. 10.1016/j.ceramint.2022.02.19210.1016/j.ceramint.2022.02.192 ↗
88. 10.1016/j.ceramint.2011.04.02510.1016/j.ceramint.2011.04.025 ↗
89. 10.1515/bglass‐2019‐000810.1515/bglass‐2019‐0008 ↗
90. 10.1016/j.jnoncrysol.2023.12240610.1016/j.jnoncrysol.2023.122406 ↗
91. 10.1016/j.msec.2019.11035110.1016/j.msec.2019.110351 ↗
92. 10.1002/jbm.a.3522310.1002/jbm.a.35223 ↗
93. 10.1016/j.actbio.2007.11.00710.1016/j.actbio.2007.11.007 ↗
94. 10.1016/j.jnoncrysol.2015.09.02610.1016/j.jnoncrysol.2015.09.026 ↗
95. 10.1186/s13287‐017‐0713‐010.1186/s13287‐017‐0713‐0 ↗
96. 10.1088/1748‐605X/aac7a510.1088/1748‐605X/aac7a5 ↗
97. 10.1089/ten.tea.2009.033710.1089/ten.tea.2009.0337 ↗
98. 10.1016/j.biomaterials.2005.01.00610.1016/j.biomaterials.2005.01.006 ↗
99. 10.1158/0008‐5472.CAN‐16‐161110.1158/0008‐5472.CAN‐16‐1611 ↗
100. 10.1016/j.jss.2004.08.02410.1016/j.jss.2004.08.024 ↗